Quality of Life in Patients with Irritable Bowel Syndrome (IBS), Assessed Using the IBS–Quality of Life (IBS-QOL) Measure After 4 and 8 Weeks of Treatment with Mebeverine Hydrochloride or Pinaverium Bromide: Results of an International Prospective Observational Cohort Study in Poland, Egypt, Mexico and China

被引：14

作者：

Xiaohua Hou

Shengliang Chen

Yali Zhang

Weihong Sha

Xiaofeng Yu

Hesham Elsawah

Afifi Fahmy Afifi

Hisham Raafat El-Khayat

Alaa Nouh

Mohamed Fathalla Hassan

Ayman Abdel Fatah

Isabel Rucker Joerg

Juan Manuel Sánchez Núñez

Rodolfo Osthoff Rueda

Grazyna Jurkowska

Michal Walczak

Ewa Malecka-Panas

Krzysztof Linke

Marek Hartleb

Gwendolyn Janssen-van Solingen

机构：

[1] Huazhong University of Science and Technology,Union Hospital, Tongji Medical College

[2] Shanghai Renji Hospital,undefined

[3] Nanfang Hospital,undefined

[4] Guangdong General Hospital,undefined

[5] Huadong Hospital,undefined

[6] Fudan University,undefined

[7] Noor El Islam Private Hospital,undefined

[8] Clinical Research Institute,undefined

[9] Privada de Constitución,undefined

[10] Torre Medica Tampico,undefined

[11] Praktyka Lekarska ul.,undefined

[12] NZOZ VITAMED Gastroenterology ul.,undefined

[13] Medical University of Łódź,undefined

[14] Gabinet Lekarski Paweł Klincewicz,undefined

[15] ul.,undefined

[16] Praktyka Lekarska,undefined

[17] ul.,undefined

[18] Abbott Product Operations AG,undefined

[19] Allschwil,undefined

[20] EPD Headquarters,undefined

来源：

Clinical Drug Investigation | 2014年 / 34卷

关键词：

Irritable Bowel Syndrome; Irritable Bowel Syndrome Patient; Irritable Bowel Syndrome Symptom; Food Avoidance; Mebeverine;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：783 / 793

页数：10

共 36 条

[1]

Drossman DA(2000)Further validation of the IBS-QOL: a disease–specific, quality–of–life questionnaire Am J Gastroenterol 95 999-1007

[2]

Patrick DL(2009)International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit J Clin Gastroenterol 43 541-550

[3]

Whitehead WE(2007)Translation and validation of a Japanese version of the irritable bowel syndrome quality of life measure (IBS-QOL–J) BioPsychoSoc Med 1 6-660

[4]

Drossman DA(2000)The impact of irritable bowel syndrome on health-related quality of life Gastroenterology 119 654-2278

[5]

Morris CB(2007)Evaluating the clinical effect and quality of life in the elderly with functional bowel disorders after treatment with pinaverium bromide J Clin Rehabil Tissue Eng Res 11 2275-411

[6]

Schneck S(1998)Quality of life in persons with irritable bowel syndrome Dig Dis Sci 43 400-662

[7]

Kawanawa M(2002)A pharmacokinetic comparison of the modified release capsule and a plain tablet formulation of mebeverine Int J Clin Pract 56 659-1453

[8]

Drossman DA(2007)Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment Am J Gastroenterol 102 1442-127

[9]

Shonozaki M(2003)Outcome measures of irritable bowel syndrome: comparison of psychometric and methodological characteristics Am J Gastroenterol 98 122-340

[10]

Gralnek IM(2006)Health-related quality of life, work productivity, and health care utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study Clin Ther 28 10-1551

← 1 2 3 4 →